Hillsdale Investment Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.53K Sell
1,400
-1,052,400
-100% -$5.3M ﹤0.01% 638
2025
Q4
$7.13M Buy
+1,053,800
New +$7.39M 0.2% 124
2024
Q3
Sell
-1,100
Closed -$7.62K 670
2024
Q2
$7.62K Sell
1,100
-485,400
-100% -$3.41M ﹤0.01% 492
2024
Q1
$3.75M Buy
486,500
+38,600
+9% +$310K 0.3% 141
2023
Q4
$3.93M Buy
447,900
+183,141
+69% +$1.34M 0.32% 118
2023
Q3
$1.93M Buy
+264,759
New +$1.97M 0.18% 175

Other funds holding MDXG

Hillsdale Investment Management's MDXG Position: Q1 2026 in Review

Hillsdale Investment Management reduced its MiMedx Group (MDXG) stake by 100% in Q1 2026, selling an estimated $5.3M and leaving 1,400 shares worth $5.53K. The position accounts for ﹤0.01% of the portfolio, ranked #638.

Hillsdale Investment Management first reported a position in MDXG in Q3 2023 and has held it in 6 quarters since. The position peaked at $7.13M in Q4 2025. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • Hillsdale Investment Management held 1,400 shares of MiMedx Group worth $5.53K as of Q1 2026.
  • Hillsdale Investment Management sold 1,052,400 MiMedx Group shares in Q1 2026, an estimated $5.3M.
  • MiMedx Group made up ﹤0.01% of Hillsdale Investment Management's portfolio in Q1 2026, its #638 holding.
  • Hillsdale Investment Management first reported a position in MiMedx Group in Q3 2023 and has held it in 6 quarters since.
  • Hillsdale Investment Management's MiMedx Group position peaked at $7.13M in Q4 2025.
  • 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.